Send us Feedback

Rochester Medical (ROCM)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ROCM » Topics » Cash Equivalents

These excerpts taken from the ROCM 10-K filed Dec 12, 2008.
Cash Equivalents
 
The Company considers all highly liquid investments with a remaining maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents includes balances in foreign accounts totaling $3.9 million and $5.6 million at September 30, 2008 and 2007 respectively. The Company maintains its cash in bank deposit accounts which, at times, may exceed the insurance limits of the Federal Deposit Insurance Corporation. The Company has not experienced any losses in such accounts.
 
Cash
Equivalents


 



The Company considers all highly liquid investments with a
remaining maturity of three months or less when purchased to be
cash equivalents. Cash and cash equivalents includes balances in
foreign accounts totaling $3.9 million and
$5.6 million at September 30, 2008 and 2007
respectively. The Company maintains its cash in bank deposit
accounts which, at times, may exceed the insurance limits of the
Federal Deposit Insurance Corporation. The Company has not
experienced any losses in such accounts.


 




This excerpt taken from the ROCM 10-K filed Dec 4, 2007.
Cash Equivalents
 
The Company considers all highly liquid investments with a remaining maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash in bank deposit accounts which, at times, may exceed the insurance limits of the Federal Deposit Insurance Corporation. The Company has not experienced any losses in such accounts.
 

EXCERPTS ON THIS PAGE:

10-K (2 sections)
Dec 12, 2008
10-K
Dec 4, 2007

RELATED TOPICS for ROCM:

"Cash Equivalents" elsewhere:

ABIOMED (ABMD)
Antares Pharma (AIS)
MGC DIAGNOSTICS Corp (ANGN)
AngioDynamics (ANGO)
Alphatec Holdings (ATEC)
BioLase Technology (BLTI)
Cantel Medical (CMN)
Haemonetics (HAE)
Home Diagnostics (HDIX)
ERBA Diagnostics, Inc. (IVD)
Kensey Nash (KNSY)
LeMaitre Vascular (LMAT)
Mesa Laboratories (MLAB)
Merit Medical Systems (MMSI)
Memry (MRY)
NeuroMetrix (NURO)
Oculus Innovative Sciences (OCLS)
OraSure Technologies (OSUR)
Pro-Dex (PDEX)
Insulet (PODD)
Protherics (PTIL)
Retractable Technologies (RVP)
SenoRx (SENO)
SonoSite (SONO)
STEN (STEN)
Vascular Solutions (VASC)
Vivus (VVUS)
Young Innovations (YDNT)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki